Area of research
Public Health, Environmental and Occupational Health · Hematology
Research interest
Research focused on Breakpoint and Chromosomal translocation, with related work in Oncology, Leukemia, Hazard ratio. Notable publications include 'The MLL recombinome of acute leukemias in 2017', 'The MLL recombinome of acute leukemias in 2013', and 'A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia'.
The KMT2A recombinome of acute leukemias in 2023
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials
Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
The MLL recombinome of acute leukemias in 2017
Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study
The MLL recombinome of acute leukemias in 2013
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation